Serum HGF and TGF-β1 levels after right portal vein embolization

Hepatology Research

Volumn 40, Issue 3, 2010, Pages 311-317

  Hayashi, Hiromitsu ^a   Beppu, Toru ^a   Sugita, Hiroki ^a   Masuda, Toshiro ^a   Okabe, Hirohisa ^a   Takamori, Hiroshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Liver atrophy; Liver hypertrophy; Portal vein embolization; Serum hepatocyte growth factor; Serum transforming growth factor beta1

Indexed keywords

SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER HYPERTROPHY; LIVER WEIGHT; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VOLUMETRY;

EID: 77954379311     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00599.x     Document Type: Article

References (28)

1. Komori K, Nagino M, Nimura Y. Hepatocyte morphology and kinetics after portal vein embolization. Br J Surg 2006, 93:745-51.
2. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995, 9:1527-36.
3. Gohda E, Tsubouchi H, Nakayama H. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988, 81:414-19.
4. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992, 89:373-7.
5. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 1994, 19:962-72.
6. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994, 19:489-97.
7. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992, 16:1227-35.
8. Fujiwara K, Nagoshi S, Ohno A. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993, 18:1443-9.
9. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res 1986, 46:2330-4.
10. Russell WE. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J Cell Physiol 1988, 135:253-61.
11. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 1985, 133:1042-50.
12. Nakamura T, Teramoto H, Tomita Y, Ichihara A. Two types of growth inhibitor in rat platelets for primary cultured rat hepatocytes. Biochem Biophys Res Commun 1986, 134:755-63.
13. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 2006, 243:364-72.
14. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007, 94:1386-94.
15. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surg 2008, 143:476-82.
16. Covey AM, Brown KT, Jarnagin WR. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 2008, 247:451-5.
17. Vauthey JN, Abdalla EK, Doherty DA. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002, 8:233-40.
18. Hayashi H, Beppu T, Sugita H. Increase in the Serum Bile Acid Level Predicts the Effective Hypertrophy of the Nonembolized Hepatic Lobe After Right Portal Vein Embolization. World J Surg 2009, 33:1933-40.
19. Enami Y, Kato H, Murakami M. Anti-transforming growth factor-beta1 antibody transiently enhances DNA synthesis during liver regeneration after partial hepatectomy in rats. J Hepatobiliary Pancreat Surg 2001, 8:250-8.
20. Nakashima S, Katano Y, Nakano I. Changes in circulating cytokine levels and lymphocyte subsets in healthy liver donors after partial hepatectomy. Hepatol Res 2007, 37:878-84.
21. Sakon M, Monden M, Gotoh M. Hepatocyte growth factor concentrations after liver resection. Lancet 1992, 339:818.
22. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992, 103:1621-4.
23. Tani M, Tomiya T, Yamada S. Regulating factors of liver regeneration after hepatectomy. Cancer Chemother Pharmacol 1994, 33:S29-32. Suppl
24. Tsubouchi H, Hirono S, Gohda E. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989, 9:875-81.
25. Tsubouchi H, Kawakami S, Hirono S. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 1992, 340:307.
26. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995, 21:106-12.
27. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988, 85:1539-43.
28. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006, 93:1091-8.